Bioqual, Inc. (BIOQ)
OTCMKTS
· Delayed Price · Currency is USD
37.51
-0.19 (-0.50%)
At close: Feb 6, 2026
Bioqual Revenue
Bioqual had revenue of $10.98M in the quarter ending November 30, 2025, a decrease of -3.65%. This brings the company's revenue in the last twelve months to $46.54M, down -7.50% year-over-year. In the fiscal year ending May 31, 2025, Bioqual had annual revenue of $48.87M, down -16.60%.
Revenue (ttm)
46.54M
Revenue Growth
-7.50%
P/S Ratio
0.72
Revenue / Employee
411.83K
Employees
113
Market Cap
33.55M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| May 31, 2025 | 48.87M | -9.72M | -16.60% |
| May 31, 2024 | 58.59M | -4.07M | -6.50% |
| May 31, 2023 | 62.66M | -3.49M | -5.27% |
| May 31, 2022 | 66.15M | 8.47M | 14.68% |
| May 31, 2021 | 57.68M | 11.32M | 24.42% |
| May 31, 2020 | Pro | Pro | Pro |
| May 31, 2019 | Pro | Pro | Pro |
| May 31, 2018 | Pro | Pro | Pro |
| May 31, 2017 | Pro | Pro | Pro |
| May 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Interpace Biosciences | 41.92M |
| China New Energy Group Company | 12.51M |
| Longduoduo Company | 2.72M |
| Aspira Women's Health | 9.34M |
| Psychemedics | 19.69M |
| Global Cord Blood | 196.10M |
| Centogene | 53.65M |
| InVitro International | 811.29K |